Skip to content

Clinical trials

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Country / region: Spain Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20141
20153
20161
20171
20192
20202
20211
20222
20231
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Terminated3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx4
Sanofi3
Baxalta now part of Shire2
CSL Behring2
Immunovant Sciences GmbH2
Laboratoire français de Fractionnement et de Biotechnologies2
Bioverativ, a Sanofi company1
Dianthus Therapeutics1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating23
Peripheral Nervous System Diseases3
Autoimmune Diseases2
Autoimmune Diseases of the Nervous System2
Nervous System Diseases2
Polyradiculoneuropathy2
Rare Diseases2
Demyelinating Diseases1
Immune System Diseases1
Myasthenia Gravis1

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.